Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 10 - Number 1





Antitumor Activities of Interleukin-27 on Melanoma

, 10(1): 41 - 46

Hiroshi Nagai, Shuntaro Oniki, Susumu Fujiwara, Mingli Xu, Izuru Mizoguchi, Takayuki Yoshimoto and Chikako Nishigori


DOI: 10.2174/187153010790827920




The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches

, 10(1): 71 - 82

Benoit Stijlemans, Ann Vankrunkelsven, Guy Caljon, Viki Bockstal, Martin Guilliams, Tom Bosschaerts, Alain Beschin, Geert Raes, Stefan Magez and Patrick De Baetselier


DOI: 10.2174/187153010790827966




Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi


Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog